|

Detection of Valvular Heart Disease Using Artificial Intelligence-based Stethoscope

RECRUITINGSponsored by Xiao-dong Zhuang
Actively Recruiting
SponsorXiao-dong Zhuang
Started2024-05-01
Est. completion2024-08-01
Eligibility
Age18 Years – 100 Years
View on ClinicalTrials.gov →

NCT06386016

Summary

The aim of this study is to develop a deep learning-based application of heart sounds in the diagnosis of valvular heart disease, which can be used to screen patients with valvular heart disease and promote earlier clinical monitoring and intervention.

Eligibility

Age: 18 Years – 100 Years
Inclusion Criteria:

1. age\>18 years
2. In the past 1 month, echocardiography was performed to diagnose valvular heart disease (positive group) and echocardiography to exclude valvular heart disease (negative group).
3. Consent to study and be able to sign informed consent

Exclusion Criteria:

1. After prosthetic valve replacement
2. Congenital heart disease (except bilobal aortic valve)
3. Hypertrophic Cardiomyopathy（HCM）
4. Pregnant, lactating women

Conditions2

Heart DiseaseValvular Heart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.